Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation?

R. Safadi; A. E'id; Y. Ilan; Y. Ashur; O. Jurim; D. Shouval

doi:10.1016/S0041-1345(97)00554-X

Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation?

R. Safadi^*
, A. E'id
, Y. Ilan
, Y. Ashur
, O. Jurim
, D. Shouval

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	2680-2683
Number of pages	4
Journal	Transplantation Proceedings
Volume	29
Issue number	6
DOIs	https://doi.org/10.1016/S0041-1345(97)00554-X
State	Published - 1997
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0041-1345(97)00554-X

Cite this

@article{435141762ea74ee1833ca37bb79a6e52,

title = "Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation?",

author = "R. Safadi and A. E'id and Y. Ilan and Y. Ashur and O. Jurim and D. Shouval",

year = "1997",

doi = "10.1016/S0041-1345(97)00554-X",

language = "אנגלית",

volume = "29",

pages = "2680--2683",

journal = "Transplantation Proceedings",

issn = "0041-1345",